Literature DB >> 6238093

T cell synergy in the primary MLR: proliferative kinetics, effector cell generation, and IL 2 production.

D R Salomon, D J Cohen, J M Williams, C B Carpenter.   

Abstract

A primary rat MLR was initiated, and on each of 8 consecutive days during the evolving culture, an aliquot of cells was separated into its constitutive helper/inducer (W3/25+) and suppressor/cytotoxic (OX8+) T cell subsets by a monoclonal antibody, Degalan-bead immunoadsorbent column technique. This allowed a detailed kinetic analysis of T cell proliferation, the generation of effector cells, and the production of IL 2 by each subset relative to net whole culture supernatant IL 2 activity. The primary MLR demonstrates an early period of helper/inducer cell proliferation, IL 2 production and accumulation, followed by a period of suppressor/cytotoxic cell (OX8+) proliferation and IL 2 consumption during which there are distinct waves of allospecific suppressor, followed by cytotoxic activity. If fresh T cells of the helper/inducer or suppressor/cytotoxic phenotype were preseparated and then cultured alone with irradiated allogeneic stimulator cells, proliferation was noted in both subsets despite no demonstrable IL 2 activity in cultures of the suppressor/cytotoxic cells. Finally, a suppressed primary MLR exhibited proliferative inhibition of both T cell subsets.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238093

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells.

Authors:  P W Bland; L G Warren
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Characterization of the Ia antigens involved in suppressor T cell generation in the rat.

Authors:  L C Uhteg; D R Salomon; D J Cohen; D V Cramer; C B Carpenter
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  In vivo treatment with anti B-220 monoclonal antibody affects T and B cell differentiation.

Authors:  V Asensi; K Himeno; I Kawamura; M Sakumoto; K Nomoto
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506.

Authors:  N Murase; A J Demetris; J Woo; M Tanabe; T Furuya; S Todo; T E Starzl
Journal:  Transplantation       Date:  1993-01       Impact factor: 4.939

5.  The autonomy of CD8+ T cells in vitro and in vivo.

Authors:  D W Mason; S J Simmonds
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2.

Authors:  A M Eggermont; E P Steller; W Matthews; P H Sugarbaker
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

7.  The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.

Authors:  C McMenamin; P G Holt
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

8.  Interleukin-2 effect on the inhibition of mixed lymphocyte reaction induced by cyclosporin A.

Authors:  H Y Kim; W S Min; H Moon; B K Bang; K S Lee; D J Kim
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.